非酒精性脂肪性肝病与新发心力衰竭风险:约1100万人的更新荟萃分析
该系统检索截至2022年3月的观察性研究,纳入11项纵向队列共11 242 231名中年个体,新发心衰97 716例,中位随访10年。非酒精性脂肪性肝病(NAFLD)与新发心衰风险中度升高相关(合并随机效应HR 1.50,95%CI 1.34-1.67,p<0.0001;I²=94.8%),且独立于年龄、性别、种族、肥胖指标、糖尿病、高血压等常见心血管危险因素。
要点
- NAFLD患者新发心衰的长期风险约为无NAFLD者的1.5倍(HR 1.50,95%CI 1.34-1.67)。
- 该关联独立于糖尿病、高血压及其他常见心血管危险因素。
- 研究为观察性设计,不能证明因果关系。
核心结论
- NAFLD与新发心衰的长期风险升高1.5倍相关,且不依赖于糖尿病、高血压和其他常见心血管危险因素的存在。
研究设计与样本
- 系统检索Scopus、Web of Science和PubMed从建库至2022年3月的观察性研究,NAFLD通过血清生物标志物/评分、国际疾病分类(ICD)编码、影像技术或肝组织学诊断。
- 纳入11项纵向队列研究,共11 242 231名来自不同国家的中年个体,中位随访10年,新发心衰97 716例。
- 采用随机效应模型进行荟萃分析,计算合并风险比(HR)及95%CI。
主要发现
- NAFLD与新发心衰风险中度升高相关(合并随机效应HR 1.50,95%CI 1.34-1.67,p<0.0001;I²=94.8%)。
- 该风险独立于年龄、性别、种族、肥胖指标、糖尿病、高血压和其他常见心血管危险因素。
- 敏感性分析未改变上述结果。
- 漏斗图未显示显著的发表偏倚。
关键数值与推荐
- NAFLD组新发心衰风险为无NAFLD组的1.50倍(HR 1.50,95%CI 1.34-1.67)。
临床怎么用
- 原文结论未据此给出临床推荐。
局限性
- 研究的观察性设计不能证明因果关系。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Recent studies reported an association between non-alcoholic fatty liver disease (NAFLD) and increased risk of new-onset heart failure (HF). However, the magnitude of the risk and whether this risk changes with severity of liver disease remains uncertain. We performed a meta-analysis of observational studies to quantify the magnitude of the association between NAFLD and risk of new-onset HF. DESIGN: We systematically searched Scopus, Web of Science and PubMed from database inception to March 2022 to identify eligible observational studies, in which NAFLD was diagnosed by serum biomarkers/scores, International Classification of Diseases (ICD) codes, imaging techniques or liver histology. The primary outcome was new-onset HF, as assessed mainly by ICD codes. Data from selected studies were extracted, and meta-analysis was performed using random-effects models to obtain summary hazard ratios (HRs) with 95% CIs. RESULTS: We identified 11 longitudinal cohort studies with aggregate data on 11 242 231 middle-aged individuals from different countries and 97 716 cases of incident HF over a median of 10 years. NAFLD was associated with a moderately higher risk of new-onset HF (pooled random-effects hazard ratio 1.50, 95% CI 1.34 to 1.67, p<0.0001; I 2=94.8%). This risk was independent of age, sex, ethnicity, adiposity measures, diabetes, hypertension and other common cardiovascular risk factors. Sensitivity analyses did not change these results. The funnel plot did not show any significant publication bias. CONCLUSION: NAFLD is associated with a 1.5-fold higher long-term risk of new-onset HF, regardless of the presence of diabetes, hypertension and other common cardiovascular risk factors. However, the observational design of the studies does not allow for proving causality.
引用
- Mantovani A, Petracca G, Csermely A, et al. Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals. Gut. 2022. PMID: 35879047. doi:10.1136/gutjnl-2022-327672
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。